Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.
Get the full story at our sister site, Drug Delivery Business News.
A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.
Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.
A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.
Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.
Phillips-Medisize announced today that it is collaborating with Subcuject to bring a wearable bolus injector to market.
Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the on-body delivery system technology that is based on osmosis is now available for the next stage of drug-specific wearable injector solution after Subcuject filed for intellectual property of the concept.
The wearable osmotic bolus injector is designed as a low-cost, patient-friendly, pre-filled wearable injector for single use. It uses osmosis to generate the force to complete a full injection cycle and requires no additional electronics or batteries.
Phillips-Medisize and Subcuject said they are exploring the opportunity to meet the demand for larger-volume drug delivery, allowing patients to self-administer certain medications almost anywhere instead of relying upon healthcare professionals to do so in a clinical setting.
“We are very p…
Paul Chaffin, SVP of Molex’s Medical and Pharmaceutical Solutions division
Paul Chaffin — most recently SVP of enterprise initiatives at Ecolab — has become SVP in charge of Molex’s Medical and Pharmaceutical Solutions division, including contract manufacturing giant Phillips-Medisize.
Chaffin will report to Molex CEO Joe Nelligan and will be a member of the company’s Global Leadership Team.
“Paul’s depth of healthcare, commercial and international experience combined with his strong leadership skills will be a big asset to not only our medical business but to the Molex leadership team. We’re confident that Paul will help fulfill our vision of expanding our global footprint with innovative and digitally connected medical solutions at a time when delivering top-quality care to patients around the world is so critical,” said Joe Nelligan, CEO of Molex.
Chaffin described the combined…